DHG Pharmaceutical JSC (VN:DHG) — Stock Price
DHG Pharmaceutical JSC (VN:DHG) is currently trading at ₫95900.00 VND, up 0.31% today. Over the past 52 weeks, shares have ranged between ₫90200.00 and ₫108100.00. This page tracks DHG Pharmaceutical JSC's live share price on the VN exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see DHG market cap overview.
DHG Pharmaceutical JSC (DHG) Stock Price Chart — Daily History & Trading Volume
The chart below tracks DHG Pharmaceutical JSC's daily closing share price and trading volume on the VN exchange over the past year, giving a clear view of recent price momentum and liquidity.
DHG Pharmaceutical JSC Income Statement — Revenue, Profit & Earnings by Year
DHG Pharmaceutical JSC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | ₫5.27 Trillion | ₫4.88 Trillion | ₫5.02 Trillion | ₫4.68 Trillion | ₫4.00 Trillion |
| Cost of Revenue | ₫2.75 Trillion | ₫2.75 Trillion | ₫2.67 Trillion | ₫2.42 Trillion | ₫2.08 Trillion |
| Gross Profit | ₫2.51 Trillion | ₫2.14 Trillion | ₫2.34 Trillion | ₫2.26 Trillion | ₫1.92 Trillion |
| Research & Development | — | — | — | — | — |
| SG&A | ₫746.41 Billion | ₫551.62 Billion | ₫599.53 Billion | ₫526.72 Billion | ₫446.08 Billion |
| Total Operating Expenses | ₫4.31 Trillion | ₫4.04 Trillion | ₫3.96 Trillion | ₫3.60 Trillion | ₫3.15 Trillion |
| Operating Income | ₫960.96 Billion | ₫841.05 Billion | ₫1.05 Trillion | ₫1.07 Trillion | ₫848.17 Billion |
| EBITDA | — | — | — | ₫1.19 Trillion | ₫959.95 Billion |
| EBIT | — | — | — | ₫1.08 Trillion | ₫860.78 Billion |
| Interest Expense | ₫25.64 Billion | ₫24.81 Billion | ₫29.53 Billion | ₫12.56 Billion | ₫12.08 Billion |
| Income Before Tax | ₫1.02 Trillion | ₫904.48 Billion | ₫1.16 Trillion | ₫1.10 Trillion | ₫864.00 Billion |
| Income Tax Expense | — | — | — | ₫111.16 Billion | ₫87.72 Billion |
| Net Income | ₫897.58 Billion | ₫778.92 Billion | ₫1.05 Trillion | ₫988.45 Billion | ₫777.22 Billion |
DHG Pharmaceutical JSC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes DHG Pharmaceutical JSC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | ₫5.17 Trillion | ₫5.96 Trillion | ₫6.11 Trillion | ₫5.17 Trillion | ₫4.62 Trillion |
| Total Current Assets | ₫3.89 Trillion | ₫4.60 Trillion | ₫4.64 Trillion | ₫4.22 Trillion | ₫3.73 Trillion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | ₫2.02 Trillion | ₫2.75 Trillion | ₫2.23 Trillion | ₫2.35 Trillion | ₫2.11 Trillion |
| Net Receivables | ₫615.18 Billion | ₫545.79 Billion | ₫553.19 Billion | ₫320.50 Billion | ₫364.37 Billion |
| Inventory | ₫1.02 Trillion | ₫1.12 Trillion | ₫1.53 Trillion | ₫1.25 Trillion | ₫1.07 Trillion |
| Property, Plant & Equipment | — | — | — | ₫678.17 Billion | ₫631.66 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | ₫983.26 Billion | ₫1.86 Trillion | ₫1.26 Trillion | ₫876.65 Billion | ₫824.52 Billion |
| Total Current Liabilities | ₫906.04 Billion | ₫1.79 Trillion | ₫1.19 Trillion | ₫811.54 Billion | ₫757.72 Billion |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | ₫587.06 Billion | ₫478.03 Billion | ₫80.71 Billion | ₫164.02 Billion |
| Total Stockholder Equity | ₫4.18 Trillion | ₫4.09 Trillion | ₫4.85 Trillion | ₫4.29 Trillion | ₫3.79 Trillion |
| Retained Earnings | ₫1.51 Trillion | ₫322.39 Billion | ₫1.08 Trillion | ₫2.98 Trillion | ₫2.48 Trillion |
DHG Pharmaceutical JSC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how DHG Pharmaceutical JSC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₫1.22 Trillion | ₫1.32 Trillion | ₫279.88 Billion | ₫901.28 Billion | ₫452.44 Billion |
| Capital Expenditures | ₫42.21 Billion | ₫88.70 Billion | ₫432.73 Billion | ₫233.99 Billion | ₫24.56 Billion |
| Free Cash Flow | ₫1.18 Trillion | ₫1.23 Trillion | ₫-152.85 Billion | ₫667.29 Billion | ₫427.88 Billion |
| Investing Cash Flow | — | — | — | ₫-353.73 Billion | ₫45.69 Billion |
| Financing Cash Flow | — | — | — | ₫-550.28 Billion | ₫-527.86 Billion |
| Dividends Paid | ₫-1.31 Trillion | ₫-980.60 Billion | ₫457.61 Billion | ₫457.61 Billion | ₫522.98 Billion |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | ₫119.01 Billion | ₫169.70 Billion | ₫85.10 Billion | ₫80.02 Billion | ₫82.56 Billion |
| Change in Cash | ₫67.32 Billion | ₫-31.21 Billion | ₫19.47 Billion | ₫-2.95 Billion | ₫-29.68 Billion |
DHG Pharmaceutical JSC Earnings History — EPS Actual vs. Analyst Estimates
Track DHG Pharmaceutical JSC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jan 19, 2026 | — | — | — |
| Oct 20, 2025 | 1551.52 | — | — |
| Jul 17, 2025 | 1753.69 | — | — |
| Apr 18, 2025 | 1971.40 | — | — |
| Jan 20, 2025 | 1592.34 | — | — |
| Oct 21, 2024 | 1153.64 | — | — |
| Jul 19, 2024 | 1424.21 | — | — |
| Apr 19, 2024 | 1644.88 | — | — |